Suppr超能文献

大豆苷元对顺铂诱导的实验大鼠血液毒性和肝毒性的影响。

Effect of daidzein on cisplatin-induced hematotoxicity and hepatotoxicity in experimental rats.

作者信息

Karale Sanjiv, Kamath Jagadish Vasudev

机构信息

Centre for Research and Development, PRIST University, Thanjavur, Tamil Nadu, India.

Department of Pharmacology, Shree Devi College of Pharmacy, Mangalore, Karnataka, India.

出版信息

Indian J Pharmacol. 2017 Jan-Feb;49(1):49-54. doi: 10.4103/0253-7613.201022.

Abstract

OBJECTIVE

The objective of the study was to investigate the effect of daidzein flavonoid on cisplatin (CP)-induced hematotoxicity and hepatotoxicity in experimental rats.

MATERIALS AND METHODS

The Wistar rats were randomly divided into four equal groups: Normal (saline 1 ml p.o.), CP (7.5 mg/kg once intraperioteneally on 16 day), test group of low dose (combination of CP and daidzein 20 mg/kg p.o. for 21 days), and test group of high dose (combination of CP and daidzein 40 mg/kg p.o. for 21 days). Blood samples were collected on 22 day from each rat and subjected for evaluation of hematological parameters such as red blood corpuscles (RBC), white blood corpuscles, hemoglobin (Hb) and platelets, and serum biomarkers such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP). Liver of each rat was excised and subjected for antioxidants evaluation such as malonyl dialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), catalase, and histopathological study.

RESULTS

Daidzein had a significant ( < 0.001) beneficial role in CP-induced hemotoxicity by increasing RBC, Hb, packed cell volume, and platelets. Daidzein also exhibited a significant ( < 0.001) protection against CP-induced hepatotoxicity by decreasing ALT, AST, ALP, and MDA level and by elevating the GSH, SOD, and catalase.

CONCLUSIONS

Daidzein attenuates CP-induced oxidative stress on blood cells and antioxidants in rats.

摘要

目的

本研究旨在探讨大豆苷元黄酮对顺铂(CP)诱导的实验大鼠血液毒性和肝毒性的影响。

材料与方法

将Wistar大鼠随机分为四组,每组数量相等:正常组(口服1 ml生理盐水)、CP组(第16天腹腔注射一次,剂量为7.5 mg/kg)、低剂量试验组(CP与大豆苷元20 mg/kg口服,共21天)和高剂量试验组(CP与大豆苷元40 mg/kg口服,共21天)。在第22天采集每组大鼠的血液样本,用于评估血液学参数,如红细胞(RBC)、白细胞、血红蛋白(Hb)和血小板,以及血清生物标志物,如丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)和碱性磷酸酶(ALP)。切除每组大鼠的肝脏,用于评估抗氧化剂,如丙二醛(MDA)、谷胱甘肽(GSH)、超氧化物歧化酶(SOD)、过氧化氢酶,并进行组织病理学研究。

结果

大豆苷元通过增加RBC、Hb、血细胞比容和血小板,对CP诱导的血液毒性具有显著(<0.001)的有益作用。大豆苷元还通过降低ALT、AST、ALP和MDA水平,并提高GSH、SOD和过氧化氢酶,对CP诱导的肝毒性表现出显著(<0.001)的保护作用。

结论

大豆苷元可减轻CP诱导的大鼠血细胞和抗氧化剂的氧化应激。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d1a/5351238/9f55fd6a884a/IJPharm-49-49-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验